This archived, self-directed learning activity is available for group/department and/or personal viewing.
There will be a total of 6 sessions where 2 videos will be released monthly until August 31, 2017.
The Brain and Cognition Discovery Foundation (BCDF) in cooperation with the Philippine Psychiatric Association (PPA) is proud to offer a new and innovative curriculum designed to create a ‘knowledge-transfer’ to both psychiatrists in-training and in-practice about Mood Disorders.
During the past decade, consensus exists that the absence of transformative treatments in Mood Disorders is a consequence of insufficient knowledge regarding disease patho-etiology, resiliency, and appropriate targets.
Advances in cellular/molecular techniques, as well as bioinformatics and trans-omic capabilities, are providing an opportunity to refine disease models, discover development, and repurpose genuinely novel approaches that are not simply palliative but are instead disease-modifying. The rapid expanse of treatment options invites the need for busy practitioners to be familiar with extant evidence in order to provide for affected patients evidence-based, measurement-informed, high-quality, coordinated care.
This eight (8) session Master Certificate Course has three objectives:
To provide participants with an up-to-date, in-depth understanding of advances in neuroscience, as it relates to disease modelling in adults with Mood Disorders.
To expose participants to recent evidence as it relates to social and cultural detereminants of health/disease and its implications for trans-domain psychopathology and Mood Disorders.
To review existing pharmacologic, psychosocial, neuromodulatory, and other treatment approaches capable of symptom management in Mood Disorders, as well as introduction of novel pharmacologic treatment pathways currently being studied as disease-modifying approaches in individuals with Mood Disorders.
Roger S. McIntyre, Executive Director, Brain and Cognition Discovery Foundation (BCDF).
Master Certificate Course on Mood Disorders
Roger McIntyre, MD, FRCPC
Professor of Psychiatry and Pharmacology
Executive Director, BCDF
Head, Mood Disorders Psychopharmacology Unit
Phenomenology of Major Depressive Disorder and Bipolar Disorder: From DSM-I to RDoC
Release Date: May 10 2017
Neurobiology of Major Depressive Disorder and Bipolar Disorder
Release Date: May 17 2017
Pharmacological Treatments of Mood Disorders
Release Date: June 7 2017
Comorbidity in Mood Disorders
Release Date: June 21 2017
Redefining Treatment Goals in Major Depressive Disorder: Cognition as SIFI
Release Date: July 12 2017
Metabolism and Mood Disorders: Implications for Mechanisms and Treatment
Release Date: August 2 2017